AMRX
Price
$7.46
Change
+$0.04 (+0.54%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
1.87B
65 days until earnings call
TEVA
Price
$17.19
Change
-$0.07 (-0.41%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
15.06B
63 days until earnings call
Interact to see
Advertisement

AMRX vs TEVA

Header iconAMRX vs TEVA Comparison
Open Charts AMRX vs TEVABanner chart's image
Amneal Pharmaceuticals
Price$7.46
Change+$0.04 (+0.54%)
Volume$39.86K
Capitalization1.87B
Teva Pharmaceutical Industries
Price$17.19
Change-$0.07 (-0.41%)
Volume$87.25K
Capitalization15.06B
AMRX vs TEVA Comparison Chart
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TEVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. TEVA commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a StrongBuy and TEVA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (AMRX: $7.42 vs. TEVA: $17.19)
Brand notoriety: AMRX: Not notable vs. TEVA: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 85% vs. TEVA: 74%
Market capitalization -- AMRX: $1.87B vs. TEVA: $15.06B
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. TEVA’s [@Pharmaceuticals: Other] market capitalization is $15.06B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 0 FA rating(s) are green whileTEVA’s FA Score has 0 green FA rating(s).

  • AMRX’s FA Score: 0 green, 5 red.
  • TEVA’s FA Score: 0 green, 5 red.
According to our system of comparison, TEVA is a better buy in the long-term than AMRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 3 TA indicator(s) are bullish while TEVA’s TA Score has 5 bullish TA indicator(s).

  • AMRX’s TA Score: 3 bullish, 4 bearish.
  • TEVA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TEVA is a better buy in the short-term than AMRX.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а +3.63% price change this week, while TEVA (@Pharmaceuticals: Other) price change was -2.94% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +14.05%. For the same industry, the average monthly price growth was +15.46%, and the average quarterly price growth was +61.88%.

Reported Earning Dates

AMRX is expected to report earnings on Aug 07, 2025.

TEVA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+14.05% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TEVA($15.1B) has a higher market cap than AMRX($1.87B). AMRX has higher P/E ratio than TEVA: AMRX (90.00) vs TEVA (22.62). AMRX YTD gains are higher at: -6.313 vs. TEVA (-22.005). TEVA has higher annual earnings (EBITDA): 1.56B vs. AMRX (400M). TEVA has more cash in the bank: 3.23B vs. AMRX (91.5M). AMRX has less debt than TEVA: AMRX (2.75B) vs TEVA (20.2B). TEVA has higher revenues than AMRX: TEVA (15.8B) vs AMRX (2.39B).
AMRXTEVAAMRX / TEVA
Capitalization1.87B15.1B12%
EBITDA400M1.56B26%
Gain YTD-6.313-22.00529%
P/E Ratio90.0022.62398%
Revenue2.39B15.8B15%
Total Cash91.5M3.23B3%
Total Debt2.75B20.2B14%
FUNDAMENTALS RATINGS
AMRX vs TEVA: Fundamental Ratings
AMRX
TEVA
OUTLOOK RATING
1..100
7214
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
69
Overvalued
PROFIT vs RISK RATING
1..100
5453
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6150
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TEVA's Valuation (69) in the Pharmaceuticals Generic industry is in the same range as AMRX (91) in the Pharmaceuticals Major industry. This means that TEVA’s stock grew similarly to AMRX’s over the last 12 months.

TEVA's Profit vs Risk Rating (53) in the Pharmaceuticals Generic industry is in the same range as AMRX (54) in the Pharmaceuticals Major industry. This means that TEVA’s stock grew similarly to AMRX’s over the last 12 months.

TEVA's SMR Rating (100) in the Pharmaceuticals Generic industry is in the same range as AMRX (100) in the Pharmaceuticals Major industry. This means that TEVA’s stock grew similarly to AMRX’s over the last 12 months.

TEVA's Price Growth Rating (50) in the Pharmaceuticals Generic industry is in the same range as AMRX (61) in the Pharmaceuticals Major industry. This means that TEVA’s stock grew similarly to AMRX’s over the last 12 months.

TEVA's P/E Growth Rating (100) in the Pharmaceuticals Generic industry is in the same range as AMRX (100) in the Pharmaceuticals Major industry. This means that TEVA’s stock grew similarly to AMRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXTEVA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
60%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
69%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
68%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 7 days ago
71%
Declines
ODDS (%)
Bearish Trend 12 days ago
78%
Bearish Trend 5 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
72%
Aroon
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TEVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGLTX36.400.35
+0.98%
Baillie Gifford Long Term Global Gr 2
VESIX40.90N/A
N/A
Vanguard European Stock Instl
JSVSX14.02N/A
N/A
Janus Henderson Small-Mid Cap Value S
GSAJX15.10N/A
N/A
Goldman Sachs Small Cap Growth Instl
ACFLX10.37N/A
N/A
American Century Focused Lg Cap Val G

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with PAHC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
+1.37%
PAHC - AMRX
44%
Loosely correlated
+0.66%
HROW - AMRX
41%
Loosely correlated
+6.65%
VTRS - AMRX
40%
Loosely correlated
-1.14%
ZTS - AMRX
38%
Loosely correlated
+0.47%
TEVA - AMRX
37%
Loosely correlated
+2.86%
More